ReCode Therapeutics Funding & Investors
Menlo Park, CA
ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases.
recodetx.comTotal Amount Raised: $357,000,000
ReCode Therapeutics Funding Rounds
Series Unknown
$15,000,000
Series Unknown Investors
Cystic Fibrosis FoundationSeries B
$50,000,000
Series B Investors
Bioluminescence VenturesMatrix Capital ManagementVida VenturesSolasta VenturesMPM CapitalLeaps by Bayersanofi-aventisPfizer Venture InvestmentsAmgenEcoR1 CapitalOsage University Partners IIOrbiMed AdvisorsSeries Unknown
$10,000,000
Series Unknown Investors
Cystic Fibrosis FoundationSeries B
$120,000,000
Series B Investors
Leaps by BayerMatrix Capital ManagementAmgensanofi-aventisPfizer Venture InvestmentsSeries B
$80,000,000
Series B Investors
EcoR1 CapitalPfizer Venture InvestmentsMPM CapitalSuperstring CapitalTekla Capital ManagementOsage University Partners IINS InvestmentOrbiMed Advisorssanofi-aventisVida VenturesColt VenturesSeries A
$80,000,000
Series A Investors
Colt VenturesOrbiMed AdvisorsVida VenturesMPM CapitalOsage University Partners IISeed
$2,000,000
Funding info provided by Diffbot.